Remove DEA Remove Extraction Remove Law
article thumbnail

Intoxicating Hemp Swindle

Project CBD

A new study from an industry advocacy group in California examines the content of dozens of unregulated intoxicating “hemp” products that are easily available in the Golden State despite being banned by state law. Before the Farm Bill, extracted CBD was $5,000 per kilo; since the Farm Bill, its down to $200, Scialdone explained.

Hemp 230
article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 196
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. Could our society miss out on potential medical breakthroughs due to outdated marijuana laws or strict regulations? In the saga of prohibition, here’s the latest news.

DEA 98
article thumbnail

DEA Publishes Notice of Proposed Rulemaking On Marijuana Research

Cannabis Law Report

The DEA says the proposed rule will see additional registered growers and more diverse variety of marijuana strains available for research. Currently, the DEA has 37 pending applications to grow marijuana for research. DEA Publishes Notice of Proposed Rulemaking On Marijuana Research.

DEA 80
article thumbnail

‘The Doors are Wide Open’: Denver Cannabis Company Gets DEA Approval To Expand Alzheimer’s Research

Cannabis Law Report

“We’re interested in how cannabinoids affect the nervous system, the brain, and in in particular, we’re very interested in Alzheimer’s disease,” said Dr. Tyrell Towle, director of chemistry and extraction at MedPharm. The new DEA research license will now change that.

DEA 105
article thumbnail

Rod Kight and Shane Pennington Discuss DEA Lawsuit (Video)

Cannabis Law Report

Rod Kight and Shane Pennington discuss the DEA lawsuit about hemp extracts. As many readers of this blog know, the… Read More.

DEA 81
article thumbnail

DEA Proposes Dramatic Increase In Marijuana And Psychedelic Production In 2022, Calling For 6,300 Percent More MDMA Alone

Cannabis Law Report

The Drug Enforcement Administration (DEA) is proposing a dramatic increase in the legal production of marijuana and psychedelics like psilocybin, LSD, MDMA and DMT to be used in research next year. It wants to double the amount of marijuana extracts, psilocybin and psilocyn, quadruple mescaline and quintuple DMT.

DEA 96